Morgan Stanley Sees Possible Near-Term Increase in M&A, Unveils 'Acquisition Likelihood Estimate Ranking Tool'
Morgan Stanley strategist Adam Parker sees possible near-term increase in M&A, unveils 'Acquisition Likelihood Estimate Ranking Tool'
Notables from his stocks with better odds of getting offers list:
- Nabors (NYSE: NBR)
- SandRidge (NYSE: SD)
- First Solar (NASDAQ: FSLR)
- Gilead (NASDAQ: GILD)
- Biogen (NASDAQ: BIIB)
- Celgene (NASDAQ: CELG)
- Express Scripts (NASDAQ: ESRX)
- Intuitive Surgical (NASDAQ: ISRG)
- Brocade (NASDAQ: BRCD)
- Smithfield (NYSE: SFD)
- Hain Celestial (NASDAQ: HAIN)
- Lionsgate (NYSE: LGF)
- Brinker (NYSE: EAT)
Latest Ratings for NBR
|Mar 2015||Goldman Sachs||Reinstates||Neutral|
|Mar 2015||Morgan Stanley||Reinstates||Overweight|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.